You are on page 1of 22

JOURNAL READING

2018 ESC/ESH
GUIDELINES FOR THE
MANAGEMENT OF
ARTERIAL
HYPERTENSION
Disusun Oleh : Klp. R8

Pembimbing :
dr. M. Dzikrul Haq Karimullah, Sp.JP, FIHA
NIP. 198508212011011005

KEPANITERAAN KLINIK ILMU PENYAKIT DALAM


RSUD KABUPATEN KEDIRI
FAKULTAS KEDOKTERAN
UNIVERSITAS WIJAYA KUSUMA SURABAYA
1
2023
2
Introduction
01 03
These 2018 ESC/ESH Guidelines for the management of The specific aims of these Guidelines were
arterial hypertension are designed for adults with to produce
hypertension, i.e. aged ≥ 18 years. pragmatic recommendations to improve the
detection and treatment of hypertension

02 04
The purpose of the review and update of To improve the poor rates of BP
these Guidelines was to evaluate and control by promoting simple and
incorporate new evidence into the Guideline
effective treatment strategie
recommendations

3
What is new and what has changed in the 2018 ESC/ESH Arterial
Hypertension Guidelines?

4
What is new and what has changed in the 2018 ESC/ESH Arterial
Hypertension Guidelines?

5
What is new and what has changed in the 2018 ESC/ESH Arterial
Hypertension Guidelines?

6
Definition of
Hypertension
Hypertension is defined as office SBP values
≥140 mmHg and/or
diastolic BP (DBP) values ≥90 mmHg.

7
Classification of office blood pressure and definitions of hypertension grade

8
Prevalence of Hypertension
The global prevalence of
hypertension was estimated
to be 1.13 billion in 2015

The overall prevalence of


hypertension in adults is
around 30 - 45%,

Hypertension becomes
progressively more common
with advancing age, with a
prevalence of >60% in
people aged >60 years.

9
Factors Influencing Cardiovascular Risk In Patients With Hypertension

10
Ten Year Cardiovascular Risk Categories (Systematic Coronary Risk
Evaluation System)

11
Blood Pressure Relationship With Risk Of
Cardiovascular And Renal Events

SBP ≥140 mmHg accounts for most BP have an independent and High DBP is associated with
of the mortality and disability burden continuous relationship with the increased CV risk and is more
(70%), and the largest number of incidence of several CV events commonly
SBP-related deaths per year are due to [haemorrhagic stroke, ischaemic elevated in older patients
ischaemic heart disease (4.9 million), stroke, myocardial infarction,
haemorrhagic stroke (2.0 million), and sudden death, heart failure, and
ischaemic stroke (1.5 million) peripheral artery disease (PAD)],
as well as end-stage renal disease

12
Classification Of Hypertension Stages According To Blood Pressure Levels,
Presence Of Cardiovascular Risk Factors

13
Conventional Office Blood Pressure Measurement

14
Routine Workup For Evaluation Of Hypertensive Patients

15
Pharmacological
Therapy For
Hypertension

16
Treatment of Hypertension
Lifestyle Changes Pharmacological
Salt restriction, moderation of ACE inhibitors, ARBs, beta-
alcohol consumption, high blockers, CCBs, and diuretics
consumption of vegetables and (thiazides and thiazide-like
fruits, weight reduction and diuretics such as chlortalidone
maintaining an ideal body and indapamide),
weight, and regular physical
activity and stop smoking

17
Pharmacological
Therapy For
Uncomplication
Hypertension

18
Pharmacological
Therapy For
Hypertension &
Coronary Artery
Disease

19
Pharmacological
Therapy For
Hypertension &
Chronic Kidney
Disease

20
Pharmacological
Therapy For
Hypertension &
Heart Failure

21
Thank You

22

You might also like